Targeting hypoxia-inducible factors with 32-134D safely and effectively treats diabetic eye disease in mice
Journal of Clinical Investigation2023cited by 31position: middledoi
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
Proceedings of the National Academy of Sciences2015cited by 135position: middledoi
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy